| Literature DB >> 30443032 |
Nirvay Sah1, Donna Lee Kuehu2, Vedbar Singh Khadka3, Youping Deng3, Karolina Peplowska4, Rajesh Jha1, Birendra Mishra5.
Abstract
Eggshell is the outermost calcified covering of an egg that protects it from microbial invasion and physical damage, and is critical for egg quality. However, understanding of the genes/proteins and the biological pathways regulating the eggshell formation is still obscure. We hypothesized that the transcriptomic analysis of the chicken uteri using RNA-sequencing may reveal novel genes and biological pathways involved in the eggshell biomineralization. RNA-sequence analysis using uteri of laying hens at 15-20 h post-ovulation (layers, n = 3) and non-laying (non-layers, n = 3) hens was carried out. About 229 differentially expressed genes (DEGs) were up-regulated in the layers compared to the non-layers. Kyoto Encyclopedia of Genes and Genomes (KEGG) and Ingenuity Pathway Analysis (IPA) revealed more than ten novel genes and biological pathways related to calcium transport and mineralization in the uterus. Based on the enriched pathways and molecular function analysis, 12 DEGs related to eggshell mineralization were further analyzed in the uteri of layers (3 h and 15-20 h post-ovulation), non-layers and molters using qPCR. Expressions of OC-116 (regulator of mineralization), OTOP2 (modulator of cellular calcium influx), CALCB (intracellular release of Ca-ions), STC2 (increases alkaline phosphatase activity), and ATP2C2 (cellular import of Ca-ions) were significantly higher in the uteri of laying hen at 15-20 h post-ovulation. This study identified the involvement of novel genes and their proposed biological pathways in the regulation of eggshell formation.Entities:
Mesh:
Year: 2018 PMID: 30443032 PMCID: PMC6237962 DOI: 10.1038/s41598-018-35203-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
The 30 most up-regulated differentially expressed genes in the uterus of layers compared to non-layers.
| Gene Name | Gene Description | Fold Change |
|---|---|---|
| OC-116 | ovocleidin-116 | 174.00 |
| OTOP2 | otopetrin 2 | 15.11 |
| TSKU | tsukushi, small leucine rich proteoglycan | 9.85 |
| PRKG2 | protein kinase, cGMP-dependent, type II | 9.47 |
| SGK1 | serum/glucocorticoid regulated kinase 1 | 8.00 |
| TC2N | tandem C2 domains, nuclear | 6.95 |
| NEU4 | sialidase 4 | 6.76 |
| GADL1 | glutamate decarboxylase like 1 | 6.62 |
| FGF1 | fibroblast growth factor 1 | 5.63 |
| LYZ | lysozyme (renal amyloidosis) | 5.45 |
| RUBCNL | RUN and cysteine rich domain containing beclin 1 interacting protein like | 5.09 |
| GAL3ST2 | galactose-3-O-sulfotransferase 2 | 4.92 |
| WSCD2 | WSC domain containing 2 | 4.76 |
| NIPAL1 | NIPA like domain containing 1 | 4.52 |
| LOC427491 | C2 calcium-dependent domain containing 4C-like | 4.43 |
| ROS1 | ROS proto-oncogene 1, receptor tyrosine kinase | 4.29 |
| PHGDH | phosphoglycerate dehydrogenase | 4.21 |
| SLC5A9 | solute carrier family 5 member 9 | 4.17 |
| FST | follistatin | 4.05 |
| FXYD2 | FXYD domain containing ion transport regulator 2 | 4.01 |
| MCMDC2 | minichromosome maintenance domain containing 2 | 3.97 |
| ALDH1L2 | aldehyde dehydrogenase 1 family member L2 | 3.87 |
| DIO2 | deiodinase, iodothyronine type II | 3.87 |
| ATP2B2 | ATPase plasma membrane Ca2 + transporting 2 | 3.83 |
| NPDC1 | neural proliferation, differentiation and control 1 | 3.69 |
| GNRHR | gonadotropin-releasing hormone receptor | 3.65 |
| SRM | spermidine synthase | 3.64 |
| OSTN | osteocrin | 3.63 |
| NTN3 | netrin 1 | 3.49 |
| OVST | ovostatin | 3.45 |
Transcripts from uteri of layers and non-layers were aligned to chicken genome and mapped genes with at least 2-fold change difference and Benjamini Hochberg q-value < 0.05 were considered differentially expressed.
The 30 most down-regulated differentially expressed genes in the uterus of layers compared to non-layers.
| Gene Name | Gene Description | Fold Change |
|---|---|---|
| SMC2 | structural maintenance of chromosomes 2 | 8.9721 |
| RRM2 | ribonucleotide reductase regulatory subunit M2 | 7.6598 |
| CCNB3 | cyclin B3 | 7.4819 |
| ASPM | abnormal spindle microtubule assembly | 6.9292 |
| RACGAP1 | Rac GTPase activating protein 1 | 6.7528 |
| CDCA3 | Cell division cycle associated 3 | 6.5454 |
| CKAP2 | cytoskeleton-associated protein 2 | 6.529 |
| UBE2C | ubiquitin conjugating enzyme E2 U (putative) | 6.4307 |
| BRCA1 | breast cancer 1 | 6.3755 |
| KNTC1 | kinetochore associated 1 | 6.2464 |
| CENPE | centromere protein E | 6.2078 |
| TPX2 | TPX2, microtubule nucleation factor | 6.076 |
| BUB1 | BUB1 mitotic checkpoint serine/threonine kinase | 6.0022 |
| CKS1B | CDC28 protein kinase regulatory subunit 1B | 5.5194 |
| KIF11 | kinesin family member 11 | 5.4992 |
| NUSAP1 | nucleolar and spindle associated protein 1 | 5.4481 |
| ADAMTS18 | ADAM metallopeptidase with thrombospondin type 1 motif 18 | 5.4347 |
| DNA2 | DNA replication helicase/nuclease 2 | 5.4128 |
| NEK2 | NIMA related kinase 2 | 5.4027 |
| PLK1 | polo like kinase 1 | 5.2537 |
| CENPF | centromere protein F | 5.1474 |
| CIT | citron rho-interacting serine/threonine kinase | 5.1143 |
| MELK | maternal embryonic leucine zipper kinase | 4.9878 |
| KPNA2 | karyopherin subunit alpha 2 | 4.9424 |
| TOP2A | topoisomerase (DNA) II alpha | 4.9072 |
| TK1 | thymidine kinase 1 | 4.8336 |
| ECT2 | epithelial cell transforming 2 | 4.8087 |
| POLQ | DNA polymerase theta | 4.7944 |
| ARHGAP19 | Rho GTPase activating protein 19 | 4.7514 |
| PLK4 | polo like kinase 4 | 4.6305 |
Transcripts from uteri of layers and non-layers were aligned to chicken genome and mapped genes with at least 2-fold change difference and Benjamini Hochberg q-value < 0.05 were considered differentially expressed.
Figure 1Heat map of thirty up- and thirty down-regulated genes in the uterus of laying and non-laying hens. RNA-seq was performed on three layers (15–20 hours p.o.) and three non-layers’ uteri. Transcripts were aligned to chicken genome and mapped genes with at least 2-fold change difference and Benjamini Hochberg q-value < 0.05 were considered differentially expressed.
Figure 2Gene Ontology enrichment analysis of differentially expressed genes in uterus of laying and non-laying hens. (a) Biological Process, (b) Molecular Function, (c) Cellular Component. The 229 up-regulated genes in the layers (15–20 hours p.o.) were subjected to DAVID database for Gene Ontology (GO) enrichment analysis. All the GO terms with a modified Fisher Exact P-value < 0.05 and threshold gene count of 2 were considered enriched.
KEGG pathway enrichment analysis of upregulated genes in the uterus of layers.
| ID | Pathway terms | Fold Enrichment | Genes |
|---|---|---|---|
| gga00770 | Pantothenate and CoA biosynthesis | 13.6 | GADL1, UPB1, VNN1 |
| gga04261 | Adrenergic signaling in cardiomyocytes | 3.4 | ATP2B2, ATP1B1, ADRB1, PLCB4, CREM, ATP1A1 |
| gga04020 | Calcium signaling pathway | 2.96 | ATP2B2, ADRB1, PLCB4, ATP2A3, ADORA2A, P2RX2, AVPR1A |
229 up-regulated genes in the layers (15–20 hours p.o.) were subjected to the DAVID database for pathway enrichment analysis. All the pathways with a modified Fisher Exact P-value < 0.05 and threshold gene count of 2 were considered enriched.
Significant canonical pathways involved in the eggshell formation in layers.
| Ingenuity Canonical Pathways | −log(p-value) |
|---|---|
| Cell Cycle Control of Chromosomal Replication | 9.68 |
| Cell Cycle: G2/M DNA Damage Checkpoint Regulation | 8.12 |
| Role of BRCA1 in DNA Damage Response | 6.73 |
| Mitotic Roles of Polo-Like Kinase | 6.7 |
| Estrogen-mediated S-phase Entry | 5.94 |
| Cyclins and Cell Cycle Regulation | 5.83 |
| Role of CHK Proteins in Cell Cycle Checkpoint Control | 5.38 |
| GADD45 Signaling | 4.33 |
| DNA damage-induced 14-3-3σ Signaling | 4.33 |
| Hereditary Breast Cancer Signaling | 4.05 |
| Serine Biosynthesis | 3.98 |
| DNA Double-Strand Break Repair by Homologous Recombination | 3.7 |
| Antiproliferative Role of TOB in T Cell Signaling | 3.63 |
| ATM Signaling | 3.49 |
| Superpathway of Serine and Glycine Biosynthesis I | 3.45 |
| Cell Cycle: G1/S Checkpoint Regulation | 3.2 |
| Breast Cancer Regulation by Stathmin1 | 3.16 |
| Calcium Transport I | 2.94 |
| Cell Cycle Regulation by BTG Family Proteins | 2.9 |
| Pancreatic Adenocarcinoma Signaling | 2.85 |
| Pyrimidine Deoxyribonucleotides De Novo Biosynthesis I | 2.82 |
| Pyridoxal 5′-phosphate Salvage Pathway | 2.5 |
| cAMP-mediated signaling | 2.31 |
| Gustation Pathway | 2.13 |
| Regulation of Cellular Mechanics by Calpain Protease | 2.07 |
| p53 Signaling | 1.93 |
| tRNA Splicing | 1.9 |
| Molecular Mechanisms of Cancer | 1.82 |
| Salvage Pathways of Pyrimidine Ribonucleotides | 1.72 |
| G-Protein Coupled Receptor Signaling | 1.68 |
| Primary Immunodeficiency Signaling | 1.67 |
| Dopamine-DARPP32 Feedback in cAMP Signaling | 1.52 |
| Oleate Biosynthesis II (Animals) | 1.49 |
| Cardiac β-adrenergic Signaling | 1.44 |
| Aryl Hydrocarbon Receptor Signaling | 1.42 |
| DNA Methylation and Transcriptional Repression Signaling | 1.41 |
| Glioma Signaling | 1.38 |
| nNOS Signaling in Skeletal Muscle Cells | 1.37 |
| Choline Degradation I | 1.36 |
| L-DOPA Degradation | 1.36 |
| Spermidine Biosynthesis I | 1.36 |
| Sulfate Activation for Sulfonation | 1.36 |
| Mismatch Repair in Eukaryotes | 1.32 |
All the differentially expressed genes in the layers were used in Ingenuity Pathway Analysis, and significant canonical pathways based on IPA scores were identified.
Figure 3Results of significant canonical pathways associated with ion-transport and the molecules involved. (a) Calcium Transport- I pathway. (b) cAMP-mediated signaling pathway. (c) Cardiac-β-adrenergic signaling pathway. The canonical pathways were analyzed using QIAGEN’s Ingenuity Pathway Analysis (IPA; QIAGEN Inc, https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis)[32]. Differentially expressed genes in the layers were subjected to IPA analysis and significant canonical pathways were identified at P-value < 0.05. Above identified canonical pathways demonstrate how the candidate molecules (genes) are involved in ion-transport.
Figure 4Gene network highlighting the candidate genes and their interaction in potentially regulating the calcium-ion transport during eggshell formation derived from QIAGEN’s Ingenuity Pathway Analysis (IPA; QIAGEN Inc., https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis)[35]. (a) Gene network for molecular transport, cellular function and maintenance, small molecule biochemistry. (b) Gene network for auditory and vestibular system development and function, organismal injury and abnormalities, cancer. Differentially expressed genes in the layers were used in Ingenuity Pathway Analysis and significant gene networks based on IPA scores were identified.
Figure 5Validation of the gene expression in the uteri of non-laying, molting and laying hens. Data represented as the mean ± SE. X-axis represents different experimental groups; Y-axis represents relative fold change for gene expression. # and $ denotes significance at P-value < 0.05.
Figure 6The proposed hypothetical model showing the identified genes and the cognate biological pathways involved in calcium transport for eggshell biomineralization in the uterus. The molecules with colored shapes and red-texts are novel genes detected in this study, whereas, those with grey texts and/or shape are genes described by previous studies[4,5,36].